Medpace Holdings (STU:01P) Cyclically Adjusted Book per Share: €19.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:01P Medpace Holdings Inc STU:01P
91 GF Score
Price €531.80
GF Value €469.57
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medpace Holdings Cyclically Adjusted Book per Share?

Medpace Holdings STU:01P -0.86% 91 Cyclically Adjusted Book per Share is €19.05 as of Jun. 2026. GuruFocus rates STU:01P with a GF Score™ of 91/100 and a GF Value™ of €469.57 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medpace Holdings's adjusted book value per share for the three months ended in Jun. 2026 was €13.630. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €19.05 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medpace Holdings's average Cyclically Adjusted Book Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-19), Medpace Holdings's current stock price is €531.80. Medpace Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €19.05. Medpace Holdings's Cyclically Adjusted PB Ratio of today is 27.92.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medpace Holdings was 29.71. The lowest was 13.75. And the median was 20.46.


Medpace Holdings  (STU:01P) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medpace Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=531.80/19.049
=27.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medpace Holdings was 29.71. The lowest was 13.75. And the median was 20.46.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medpace Holdings Cyclically Adjusted Book per Share Related Terms


Medpace Holdings Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medpace Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings Cyclically Adjusted Book per Share Chart

Medpace Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.63 17.12 19.13 19.74

Medpace Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.46 18.35 18.33 18.82 19.05

STU:01P vs RVTY, CRL, ICLR: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Medpace Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Cyclically Adjusted PB Ratio falls into.


STU:01P
91GF Score
Medpace Holdings Inc STU:01P
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medpace Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medpace Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=13.63/333.9520*333.9520
=13.630

Current CPI (Jun. 2026) = 333.9520.

Medpace Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201609 13.343 241.428 18.457
201612 14.239 241.432 19.696
201703 14.274 243.801 19.552
201706 13.416 244.955 18.290
201709 12.444 246.819 16.837
201712 11.890 246.524 16.107
201803 11.771 249.554 15.752
201806 13.087 251.989 17.344
201809 13.658 252.439 18.068
201812 14.545 251.233 19.334
201903 15.589 254.202 20.480
201906 16.189 256.143 21.107
201909 17.725 256.759 23.054
201912 18.040 256.974 23.444
202003 18.540 258.115 23.987
202006 18.665 257.797 24.179
202009 18.986 260.280 24.360
202012 18.638 260.474 23.896
202103 20.342 264.877 25.647
202106 20.055 271.696 24.650
202109 21.562 274.310 26.250
202112 23.389 278.802 28.016
202203 16.159 287.504 18.770
202206 8.743 296.311 9.854
202209 11.485 296.808 12.922
202212 11.671 296.797 13.132
202303 10.437 301.836 11.548
202306 11.728 305.109 12.837
202309 14.496 307.789 15.728
202312 16.492 306.746 17.955
202403 20.114 312.332 21.506
202406 23.034 314.175 24.484
202409 25.467 315.301 26.973
202412 26.087 315.605 27.604
202503 18.462 319.799 19.279
202506 5.240 322.561 5.425
202509 8.894 324.800 9.145
202512 13.812 324.054 14.234
202603 18.227 330.213 18.433
202606 13.630 333.952 13.630

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €19.05 mean?
Medpace Holdings (STU:01P) has a Cyclically Adjusted Book per Share of €19.05 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medpace Holdings and its competitors.
Is Medpace Holdings' Cyclically Adjusted Book per Share too high?
Medpace Holdings' current Cyclically Adjusted Book per Share is €19.05. Overall, Medpace Holdings has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medpace Holdings' Cyclically Adjusted Book per Share compare to RVTY and CRL?
Medpace Holdings' Cyclically Adjusted Book per Share of €19.05 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medpace Holdings and its competitors. Medpace Holdings's current Cyclically Adjusted Book per Share is €19.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medpace Holdings (STU:01P) is currently considered Modestly Overvalued. The stock's GF Value™ is €469.57, compared to a current price of €531.80 — trading 13.3% above its estimated fair value. The current Cyclically Adjusted Book per Share is €19.05. Medpace Holdings' overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medpace Holdings (STU:01P), the current Cyclically Adjusted Book per Share is €19.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medpace Holdings (STU:01P) Overvalued in 2026?

Based on GuruFocus' analysis, Medpace Holdings stock appears to be overvalued. The current stock price of €531.80 is trading 13.3% above its estimated GF Value™ of €469.57. GuruFocus considers Medpace Holdings to be Modestly Overvalued.

Key valuation signals for STU:01P:

  • Cyclically Adjusted Book per Share: €19.05
  • GF Value™: €469.57 vs. price of €531.80 (13.3% above fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the STU:01P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medpace Holdings Business Description

Address 5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
91GF Score

Get the complete analysis for STU:01P

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€531.80
Price
€469.57
GF Value